Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03284788
Other study ID # IRB201701609-N
Secondary ID K01HL141535PA-16
Status Completed
Phase N/A
First received
Last updated
Start date August 8, 2018
Est. completion date October 1, 2020

Study information

Verified date September 2023
Source University of Florida
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this pilot, feasibility study is to investigate the acceptability of an acceptance-based therapy healthy lifestyle intervention in adolescent girls with overweight/obesity.


Description:

Participants will attend 2 baseline clinic visits and adolescents will participate in an ABT healthy lifestyle intervention. The intervention will include 15 sessions over 6 months. A post-treatment visit will occur.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date October 1, 2020
Est. primary completion date July 30, 2020
Accepts healthy volunteers No
Gender Female
Age group 14 Years to 19 Years
Eligibility Inclusion Criteria: - Adolescent girls between ages 14-19 with overweight or obesity above the 85th percentile for sex and age as determined by CDC growth charts Exclusion Criteria: - Known pregnancy or plans to become pregnant in the next 2 years - Any condition prohibiting physical activity - A diagnosis of cardiovascular disease or diabetes - Have active cancer or cancer requiring treatment in the past 2 years - Have active or chronic infections (e.g., HIV or TB) - Have active kidney disease or lung disease - An eating disorder or substance abuse disorder - Having begun a course of or changed the dosage of any medications known to affect appetite or body composition within the previous 3 months - Weight loss greater than or equal to 5% in the previous 6 months - If they do not follow the study plan

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
ABT Weight Loss Intervention
This includes 15 sessions that are each 90 minutes in length. Intervention sessions will be weekly for the first 2 months, bi-weekly for the next 2 months, and monthly for the last 2 months.

Locations

Country Name City State
United States HealthStreet and University of Florida Gainesville Florida

Sponsors (4)

Lead Sponsor Collaborator
University of Florida National Heart, Lung, and Blood Institute (NHLBI), StayWell, WellCare Health Plans, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants Recruited Number of teens who enrolled and completed both initial baseline visits. The recruitment strategy will be deemed 'feasible' if 15 participants are recruited within the 8 weeks. Baseline; Week 8
Primary Percentage of Participants Who Did Not Complete the Intervention. The attrition strategy will be deemed "feasible" if there is less than 50% attrition at the end of the 6-month intervention. This percentage details attrition, or the percentage of participants who did not complete the intervention. Baseline; Month 6
Primary Percentage of Participants Who Decide to Participate in the Intervention Of the participants who completed baseline visits, this percentage details what percentage of enrollees decided to participate in the intervention. The study will be deemed "acceptable" if at least 80% of enrolled participants decide to participate in the intervention. Baseline; Week 1
Primary Percentage of Participants Who Attend All Intervention Sessions. This percentage details the percentage of those who attended all 15 intervention sessions among intervention completers (n=11). The study will be deemed 'acceptable' if at least 70% of intervention completers attend all sessions. Week 1; Week 24
Secondary Change in BMI Z-score Body mass index (BMI) z-scores are measures of weight adjusted for the height, age, and sex of the child. BMI z-scores correspond with growth chart percentiles. These scores are calculated with an external reference rather than internal references. In this study, the Centers for Disease Control and Prevention SAS program was used to calculate scores based on 2000 CDC growth charts. Additionally, a clinically significant change in BMI z-score was defined as greater than or equal to -0.15 as this decrease has shown improvements in one or more cardiovascular disease risk factor. The central z-score value is 0, representing the population mean, and standard deviations below the mean indicate better outcomes. Baseline; Month 6
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2